Kingfisher Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-10,944
Closed -$1.24M 159
2019
Q4
$1.24M Sell
10,944
-33
-0.3% -$3.62K 0.58% 65
2019
Q3
$1.19M Buy
10,977
+491
+5% +$51.2K 0.71% 62
2019
Q2
$1.02M Sell
10,486
-49
-0.5% -$4.47K 0.63% 59
2019
Q1
$960K Sell
10,535
-83
-0.8% -$7.43K 0.61% 59
2018
Q4
$966K Buy
10,618
+25
+0.2% +$2.34K 0.69% 54
2018
Q3
$1.04M Buy
10,593
+160
+2% +$14.8K 0.56% 64
2018
Q2
$893K Sell
10,433
-558
-5% -$46.6K 0.57% 69
2018
Q1
$882K Buy
10,991
+135
+1% +$11.1K 0.56% 69
2017
Q4
$877K Buy
10,856
+46
+0.4% +$3.68K 0.56% 70
2017
Q3
$841K Sell
10,810
-268
-2% -$22.3K 0.56% 72
2017
Q2
$983K Buy
11,078
+146
+1% +$12.3K 0.67% 66
2017
Q1
$881K Buy
10,932
+4,015
+58% +$314K 0.64% 67
2016
Q4
$493K Buy
+6,917
New +$543K 0.37% 88

Other funds holding MDT

Kingfisher Capital's MDT Position: Q1 2020 in Review

Kingfisher Capital sold out of Medtronic (MDT) in Q1 2020, closing a stake of 10,944 shares — an estimated $1.24M sold.

Kingfisher Capital first reported a position in MDT in Q4 2016 and held it in 13 quarters. The position peaked at $1.24M in Q4 2019. 1,762 funds tracked by Wall St. Rank hold MDT as of Q1 2020.

  • Kingfisher Capital reported no remaining Medtronic position as of Q1 2020 after selling out during the quarter.
  • Kingfisher Capital sold 10,944 Medtronic shares in Q1 2020, an estimated $1.24M.
  • Kingfisher Capital first reported a position in Medtronic in Q4 2016 and held it in 13 quarters.
  • Kingfisher Capital's Medtronic position peaked at $1.24M in Q4 2019.
  • 1,762 funds tracked by Wall St. Rank held Medtronic as of Q1 2020.

Based on Kingfisher Capital's 13F filing for Q1 2020, filed 14 May 2020.